Study of Cognition, Adolescents and Mobile Phones (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/study-of-cognition-adolescents-and-mobile-phones
This project is a collaboration with Imperial College, London, UK. The official project website is http://www.scampstudy.org/ The Study of Cognition, Adolescents and Mobile Phones (SCAMP) is the large
NETCELL Phase 5 - Core support to the National Malaria Control Programme in Tanzania (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/netcell-phase-5-core-support-to-the-national-malaria-control-programme-in-tanzania
Since its inception in 2002 the NETCELL Project has played a key role in supporting the National Malaria Control Programme (NMCP) of the Tanzanian Ministry of Health and Social Welfare, by managing th
Compensatory Evolution and Epistasis in Multidrug-Resistant Mycobacterium (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/compensatory-evolution-and-epistasis-in-multidrug-resistant-mycobacterium
Multidrug-resistant bacteria are a global threat to public health and the economy. Studies in model organisms suggest compensatory evolution and epistatic interactions between drug resistance-conferri
Longitudinal tracking of B cell and functional antibody responses to SARS-CoV-2 and other human coronaviruses in Africa (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/longitudinal-tracking-of-b-cell-and-functional-antibody-responses-to-sars-cov-2-and-other-human-coronaviruses-in-africa
Background and Rationale: In contrast to soaring COVID-19 case numbers during pandemic waves in the Americas and Europe, large parts of Africa have reported relatively low numbers of SARS-CoV-2 infect
Feasibility and Economic Evaluation of Improved Child Deworming (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/feasibility-and-economic-evaluation-of-improved-child-deworming
Parasitic worm infections are still very common, particularly among children living in areas with limited access to safe drinking water and adequate sanitation. Additionally, this age group is at high
Nutrition in City Ecosystems (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/nutrition-in-city-ecosystems
The Nutrition in City Ecosystems (NICE) project connects the demand and supply side of food systems, engages women and youth - including through social business models - and builds local governance ca
The South African cervical cancer screening cohort: improving cervical cancer control in women living in South Africa (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/the-south-african-cervical-cancer-screening-cohort-improving-cervical-cancer-control-in-women-living-in-south-africa
Background: Cervical cancer is the leading cause of cancer-related mortality in South Africa. Screening for cervical pre-cancer is available in South Africa, yet, a systematic approach to monitor and
5G Exposure, Causal Effects, and Risk Perception through Citizen Engagement (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/5g-exposure-causal-effects-and-risk-perception-through-citizen-engagement
There is few knowledge about potential health effects of everyday-emerging applications of wireless technology. The importance of this concern is more remarkable among young people and workers, the mo
Exposure to Electromagnetic FIelds and Planetary Health (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/exposure-to-electromagnetic-fields-and-planetary-health
The ETAIN ( E xposure T o electrom A gnetic f I elds and pla N etary health) project takes a planetary health perspective to develop and validate approaches to assess the impact of existing and novel
The Typhoid Vaccine Acceleration Consortium (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/the-typhoid-vaccine-acceleration-consortium
The Typhoid Vaccine Acceleration Consortium (TyVAC), a partnership between the Center for Vaccine Development at the University of Maryland School of Medicine, the Oxford Vaccine Group at the Universi
